Carmen Baldino's guest appearances

Carmen Baldino

HealthTree Podcast for Multiple Myeloma

Johns Hopkins

Stephen Russell

Adam Cohen

David Siegel

Mike Thompson

Beth Israel

Damian Green

Sarah Cannon

Keith Stewart

Mark Newman

Paul Richardson

Stephen Harding

Kenneth Anderson

Vincent Rajkumar

Thomas Martin

OwlTail

Patients who have high-risk genetic features like the 14;16 translocation need new treatment options. Dr. Carmen Baldino of Jasco Pharmaceuticals and Dr. Kelvin Lee of the Roswell Park Cancer Institute are working on a potentially curative solution for patients with this high-risk translocation using a PIM2 Kinase inhibitor called JP-11646. Learn more about this proposal for the Myeloma Crowd Research Initiative to address the unmet needs for high-risk patients.

Myeloma Crowd Radio/MCRI: Dr. Carmen Baldino, PhD and Dr. Kelvin Lee, MD